Study: PET/CT improves treatment plan for metastatic melanoma

04/15/2012 | MolecularImaging.net

In 32 patients who had clinically evident stage III and oligometastatic stage IV melanoma, 12% of PET/CT scans identified unexpected metastases, according to a study published in the American Journal of Roentgenology. The scans led to a change in patient management, with surgery canceled for two patients and the treatment plan changed for two others. The findings indicate the technique can be useful as part of preoperative measures for such patients, researchers said.

View Full Article in:

MolecularImaging.net

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Litigation & Investigations EMEA
Gilead Sciences
Stockely Park
Assistant General Counsel/Senior Corporate Counsel
Genentech
South San Francisco, CA
Senior Analyst Compliance
Edwards Lifesciences
Irvine, CA
Legal Counsel
Alcon
Fort Worth, TX
Director, Senior Legal Counsel
Alcon
Fort Worth, TX